We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
-16.6%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$1.04B
AUM Growth
-$3.41M
Cap. Flow
+$220M
Cap. Flow %
21.29%
Top 10 Hldgs %
43.95%
Holding
852
New
247
Increased
177
Reduced
137
Closed
202

Sector Composition

Rank Sector Weight
1 Healthcare 28.69%
2 Financials 13.57%
3 Materials 7.25%
4 Technology 4.61%
5 Industrials 3.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INVZW
76
DELISTED
Innoviz Technologies Warrant
INVZW
$1.27M 0.12%
721,715
FACA
77
DELISTED
Figure Acquisition Corp. I
FACA
$1.22M 0.12%
124,611
-7,472
-6% -$73.2K
GOOGL icon
78
Alphabet (Google) Class A
GOOGL
$4.37T
$1.21M 0.12%
+11,100
New +$1.31M
TEVA icon
79
Teva Pharmaceuticals
TEVA
$42.1B
$1.19M 0.11%
158,084
-1,486
-0.9% -$12.9K
ADP icon
80
Automatic Data Processing
ADP
$109B
$1.15M 0.11%
5,491
+1,508
+38% +$330K
WES icon
81
Western Midstream Partners
WES
$19.6B
$1.13M 0.11%
+46,300
New +$1.18M
C icon
82
PUT
Citigroup
C
$227B
$1.13M 0.11%
65,100
TTWO icon
83
PUT
Take-Two Interactive
TTWO
$47.4B
$1.12M 0.11%
62,500
+1,300
+2% +$165K
SLGC
84
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$1.12M 0.11%
247,226
KRE icon
85
State Street SPDR S&P Regional Banking ETF
KRE
$4.56B
$1.11M 0.11%
19,144
+10,844
+131% +$677K
MRVL icon
86
Marvell Technology
MRVL
$187B
$1.09M 0.11%
+25,000
New +$1.42M
HUGS
87
DELISTED
USHG Acquisition Corp.
HUGS
$1.05M 0.1%
+106,876
New +$1.07M
CRM icon
88
Salesforce
CRM
$162B
$1.03M 0.1%
+6,250
New +$1.1M
SNCE
89
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$1.02M 0.1%
25,355
-12,411
-33% -$907K
CNGL
90
DELISTED
Canna-Global Acquisition Corp. Class A Common Stock
CNGL
$1M 0.1%
100,000
-86,737
-46% -$868K
FCAX
91
DELISTED
Fortress Capital Acquisition Corp.
FCAX
$985K 0.1%
100,000
SDAC
92
DELISTED
Sustainable Development Acquisition I Corp. Class A Common Stock
SDAC
$981K 0.09%
100,000
FSSI
93
DELISTED
Fortistar Sustainable Solutions Corp. Class A Common Stock
FSSI
$981K 0.09%
100,000
-75,000
-43% -$736K
ACII
94
DELISTED
Atlas Crest Investment Corp. II
ACII
$981K 0.09%
100,000
-24,588
-20% -$241K
PICC
95
DELISTED
Pivotal Investment Corporation III
PICC
$981K 0.09%
100,000
FXI icon
96
CALL
iShares China Large-Cap ETF
FXI
$4.35B
$913K 0.09%
+282,500
New +$8.85M
TWTR
97
PUT
DELISTED
Twitter, Inc.
TWTR
$903K 0.09%
+88,200
New +$3.78M
VORB
98
DELISTED
Virgin Orbit Holdings, Inc. Common Stock
VORB
$882K 0.09%
+230,400
New +$1.14M
DMYS
99
DELISTED
dMY Technology Group, Inc. VI
DMYS
$864K 0.08%
88,392
VYX icon
100
CALL
NCR Voyix
VYX
$1.09B
$858K 0.08%
+442,871
New +$9.45M

Similar funds

Cowen and Company's Q2 2022 Portfolio in Review

As of Q2 2022, Cowen and Company held 852 positions worth $1.04B, down 0.33% from $1.04B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Cowen and Company deployed $220M of net new capital in Q2 2022, opening 247 new positions and adding to 177 existing holdings. Its largest new stake was Avidity Biosciences: 2,264,150 shares worth $32.9M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 40% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was Social Capital Hedosophia Holdings Corp. VI, an estimated $16.9M trimmed.

  • Cowen and Company's largest Q2 2022 buy was Avidity Biosciences: 2,264,150 shares worth $32.9M.
  • Cowen and Company added most to ARK Innovation ETF in Q2 2022, an estimated $72.6M increase.
  • Cowen and Company's biggest Q2 2022 reduction was Social Capital Hedosophia Holdings Corp. VI, cutting an estimated $16.9M.
  • Cowen and Company fully exited Rivian in Q2 2022, selling an estimated $26.8M.
  • Cowen and Company's ten largest holdings make up 44% of its $1.04B portfolio in Q2 2022.
  • Cowen and Company opened 247 new positions and closed 202 in Q2 2022.
  • Cowen and Company's portfolio value fell 0.33% quarter-over-quarter to $1.04B.

Based on Cowen and Company's 13F filing for Q2 2022, filed 5 Aug 2022.